SEARCH

SEARCH BY CITATION

References

  • 1
    Mollison PL, Engelfreit CP, Contreras M. Blood Transfusion in Clinical Medicine. Oxford : Blackwell Science, 1993.
  • 2
    Tovey LAD, Townley A, Stevenson BJ, Taverner J. The Yorkshire antenatal anti-D immunoglobulin trial in primigravidae. Lancet 1983; 2: 244246.
  • 3
    National Blood Transfusion Service Immunoglobulin Working Party. Recommendations for the use of anti-D immunoglobulin. Prescribers Journal 1991; 31: 135145.
  • 4
    Wagstaff W. Practical aspects of anti-D prophylaxis of haemolytic disease of the newborn. Broadsheet No. 90; Association of Clinical Pathologists 1978.
  • 5
    Mollison PL, Engelfriet CP, Contreras M. Blood Transfusion in Clinical Medicine. Oxford : Blackwell Science, 1987.
  • 6
    Marsh WL. Technicon Symposium on automation in analytical chemistry. 503, New York , 1965; Medical.
  • 7
    Letsky EA, DeSilva M. Preventing Rh immunisation: BMJ 1994; 309: 213214.
  • 8
    Duguid JKM, Bromilow I. Value of Kleihauer testing after administration of anti-D immunoglobulin. BMJ 1994; 309:240.
  • 9
    Love EM, Shwe KH. Kleihauer testing need not be abandoned [letter]. BMJ 1994; 309: 805.
  • 10
    Urbaniak SJ, Main R, Fraser N. Kleihauer Testing Quality Assurance Scheme exists [letter]. BMJ 1994; 309: 805.
  • 11
    Duguid JKM, Bromilow IM. Kleihauer testing, subjectivity leads to inaccuracy [letter]. BMJ 1994; 309:805.
  • 12
    Van Dijk BA, DeMan CJM, Kunst VAJM. Kleihauer testing, sub jectivity leads to inaccuracy [letter]. BMJ 1994; 309: 805806.
  • 13
    Murphy WG, Ghosh S, Hughes RH, Craig JIO, Greer IA. Kleihauer testing, many cases of sensitisation may be avoidable [letter]. BMJ 1994; 309: 806.